Moody’s affirms Summit Health’s ‘A2’ rating

Moody’s Investors Service has affirmed Chambersburg, Pa.-based Summit Health’s “A2” rating, affecting approximately $119.3 million of outstanding debt.

Advertisement

The rating affirmation is based on Summit’s strong operating results and leading market position.

Summit Health also faces challenges, including service area competition, pressured volumes and the upcoming implementation of a new EHR.

The outlook is stable, reflecting Moody’s Investors Service’s expectation that Summit will continue to generate solid operating results.

More articles on healthcare finance:
Moody’s assigns ‘A1’ rating to Arkansas Children’s Hospital’s bonds
The top 8 takeaways from HFMA’s 2016 National Institute
CMS considers modifications to ambitious Medicare Part B payment experiment

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.